SCHEMBL10028191

SCHEMBL10028191

c1cc2ccc3oc4cc(Oc5cc6ccc7oc8cccc9ccc%10oc(c5)c6c7-c%10c98)cc5ccc6oc(c1)c2c3-c6c54

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP1A1 P04798 2/20 0.32
CYP1B1 Q16678 2/20 0.32
CYP1A2 P05177 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PTGS2 P35354 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.31
MAOA P21397 3/20 0.31
MTNR1A P48039 1/20 0.31
AHR P35869 3/20 0.30
ERBB2 P04626 1/20 0.30
FYN P06241 1/20 0.30
ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10028102 0.87 NPC1 (0.42) NPC1POLBRAB9AL3MBTL1CYP1A1
SCHEMBL10028079 0.82 ALDH1A1 (0.48) NPC1RAB9AL3MBTL1CYP1A1CYP1B1
SCHEMBL29737512 0.82 ALDH1A1 (0.48) NPC1RAB9AL3MBTL1CYP1A1CYP1B1
SCHEMBL10028189 0.81 CYP1A2 (0.36) CYP1A1CYP1B1CYP1A2ALDH1A1CYP3A4
SCHEMBL17304507 0.78 ALDH1A1 (0.36) L3MBTL1CYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL10028190 0.78 PGR (0.37) NPC1RAB9ACYP1A1CYP1B1CYP1A2
SCHEMBL21187530 0.75 ALDH1A1 (0.58) L3MBTL1CYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL10028194 0.75 ALDH1A1 (0.34) RAB9ACYP1A1CYP1B1CYP1A2ALDH1A1
SCHEMBL10028203 0.74 CYP1A2 (0.39) NPC1RAB9AL3MBTL1CYP1A1CYP1A2
SCHEMBL10028192 0.74 MEN1 (0.46) NPC1RAB9AL3MBTL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 NPC1 1014/4885POLB 1369/4885RAB9A 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.